Peter S. Greenleaf - Chief Executive Officer, Director at Aurinia Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
AUPH on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Peter S. Greenleaf since 06 Mar 2025

Holdings reported by Peter S. Greenleaf for Aurinia Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,840,379 $26,151,785 $14.21 02 Mar 2026 Direct
Employee Stock Option (right to buy) 328,424 27 Feb 2026 Direct Common Stock

Transactions reported by Peter S. Greenleaf for Aurinia Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.